Investigating how body fat affects frailty in older patients with lung disease
Role of visceral adipose tissue in frailty among patients with Idiopathic Pulmonary Fibrosis
['FUNDING_OTHER'] · UNIVERSITY OF PENNSYLVANIA · NIH-10912580
This study is looking at how extra body fat might affect weakness in older adults with idiopathic pulmonary fibrosis (IPF), and it hopes to find ways to help improve their health and well-being.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10912580 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the impact of body composition, particularly visceral adipose tissue, on frailty in patients with idiopathic pulmonary fibrosis (IPF). The study aims to identify how increased body fat may contribute to frailty, which is a significant concern for older adults with IPF. By using bioelectrical impedance analysis, researchers will assess body composition and its relationship to frailty, potentially leading to new insights into managing this condition. The findings could help in developing targeted interventions to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who have been diagnosed with idiopathic pulmonary fibrosis.
Not a fit: Patients who are younger than 65 or do not have idiopathic pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved management strategies for frailty in patients with idiopathic pulmonary fibrosis, enhancing their quality of life.
How similar studies have performed: Previous research has indicated a link between body composition and frailty, suggesting that this approach may yield valuable insights, although the specific focus on visceral adipose tissue in IPF is relatively novel.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ANDERSON, MICHAELA RESTIVO — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: ANDERSON, MICHAELA RESTIVO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus